Exploring innovative technologies to enhance breast cancer treatment

Description

Metastatic breast cancer results in tumour cells spreading to other parts of the body, most commonly the liver, brain, bones, or lungs. Nearly 30 percent of women diagnosed with early-stage breast cancer will develop metastatic disease, with current therapies shown to be highly aggressive, often leading to harsh side effects which can substantially diminish the patient’s quality of life.

Researchers from Monash University’s Institute of Pharmaceutical Sciences (MIPS) collaborated with the Queensland University of Technology (QUT) in an important step forward for research into the treatment of metastatic breast cancer.

By combining two innovative technologies, the research team have presented promising results in advancements towards reducing primary tumour growth and its spread to the human bone as well as to other organs.